Publications scientifiques

Les activités scientifiques de GeNeuro reposent sur plus de 25 années de recherche, effectuée en interne et en collaboration avec des groupes universitaires renommés.

ECTRIMS 2109 – Neuroprotective effects of temelimab in relapsing-remitting MS patients extend to 96 weeks

Phase IIb safety and efficacy data on temelimab at week 96 from the ANGEL-MS study

https://geneuro.ch/data/news/P1379-Ectrims-2019.pdf

Neural Cell Responses Upon Exposure to Human Endogenous Retroviruses

Variation in proviral content among human genomes mediated by LTR recombination

Rescuing the negative impact of human endogenous retrovirus envelope protein on oligodendroglial differentiation and myelination

GNbAC1 shows efficacy on MRI measures of neurodegeneration in relapsing-remitting MS patients over 48 weeks

Robert Glanzman at the 26th Annual Meeting of the European Charcot Foundation (November 2018) in Baveno, Italy

https://www.pnas.org/content/116/30/15216

HERV-W-Env involvement in human T1D pathogenesis

S. Levet, J. Joanou, N. Queruel, J.Pierquin & H. Perron

https://geneuro.ch/data/news/18-05-22-Poster-ADA-2018-V2.pdf